The SARS-CoV-2 and Influenza A+B Antigen Combo Rapid Test (Nasopharyngeal Swab) is a rapid chromatographic immunoassay for the qualitative detection of SARS-CoV-2 Nucleocapsid protein, Influenza A and Influenza B virus antigens in nasopharyngeal swab specimens from individuals with suspected SARS-CoV-2/Influenza infection in conjunction with clinical presentation and the results of other laboratory tests.
Product Features
Fast results
Easy visual interpretation
Simple operation, no equipment required
High accuracy
PRODUCT SPECIFICATION
- PrincipleChromatographic Immunoassay
- FormatCassette
- SpecimenNasopharyngeal Swab
- CertificateCE
- Reading Time15 minutes
- Pack20 T
-
Storage Temperature
2-30°C
- Shelf Life2 Years
- Sensitivity97.6%(COVID-19) / 94.7%(Influenza A) / 93.0%(Influenza B)
- Specificity99.7%(COVID-19) / 98.2%(Influenza A) / 97.7%(Influenza B)
- Accuracy99.1%(COVID-19) / 97.7%(Influenza A) / 97.0%(Influenza B)
Ordering Information
- Cat. No.ISIC-525
- ProductSARS-CoV-2 and Influenza A+B Antigen Combo Rapid Test
- SpecimenNasopharyngeal Swab
- Pack20 T
- Cut-OffSee Insert
